Mihai Raduca

Dr. Mihai Raduca

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
TCThomaz de A. Costa
Thomaz de A. Costa
MRMihai Raduca
Mihai Raduca
JRJulio C. Rocha
Julio C. Rocha
MNMiguel A. Novak
Miguel A. Novak
RCRafael Cassaro
Rafael Cassaro
Maria VazMaria Vaz
Maria Vaz
Two one-dimensional coordination polymers were synthesized: [M(hfac)2(9-PhentNIT)]n, where M = Mn (1) or Co (2), hfac− is hexafluoroacetylacetonato and 9-PhentNIT is a new stable nitronyl nitroxide organic radical, 2-(9-phenanthrenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide. These two complexes are isomorphous and crystallized with metal ions coordinated by two aminoxyl groups, arising from two bridging 9-PhentNIT radicals and two hfac− chelating ligands. The asymmetric unit has two independent metal(II) sites, resulting in two crystallographically independent chains. The investigation of their magnetic properties shows that both compounds form ferrimagnetic chains with strong antiferromagnetic coupling between S = 5/2 or 3/2 and 1/2 spin carriers. The anisotropic compound 2 shows the highest blocking temperature TB = 15.5 K reported so far for a single chain magnet (SCM) and exhibits magnetic hysteresis with low coercivity up to 22 K. In addition, we found evidence for magnetic irreversibility and relaxation of a small portion of long chains up to about 50 K.

24 May 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMihaela Turtoi
Mihaela Turtoi
MAMaria Anghelache
Maria Anghelache
APAndrei A. Patrascu
Andrei A. Patrascu
MDMariana Deleanu
Mariana Deleanu
GVGeanina Voicu
Geanina Voicu
DPDelia-Laura Popescu
Delia-Laura Popescu
A wide variety of metal-based compounds have been obtained and studied for their antitumor activity since the intensely used cytostatic drugs (e.g., cisplatin) failed to accomplish their expected pharmacological properties. Thus, we aimed to develop a new vanadium-based drug and assess its antitumor properties using the human hepatocarcinoma (HepG2) cell line. The compound was synthesized from vanadyl sulfate, DL-valine, and o-vanillin and was spectrally and structurally characterized (UV-Vis, IR, CD, and single-crystal/powder-XRD). Compound stability in biological media, cell uptake, and the interaction with albumin were assessed. The mechanisms of its antitumor activity were determined compared to cisplatin by performing cytotoxicity, oxidative and mitochondrial status, DNA fragmentation, β-Tubulin synthesis investigation, and cell cycle studies. Herein, we developed a macrocyclic tetranuclear oxidovanadium(V) compound, [(VVO)(L)(CH3O)]4, having coordinated four Schiff base (H2L) ligands, 3-methoxysalicylidenvaline. We showed that [(VVO)(L)(CH3O)]4: (i) has pH-dependent stability in biological media, (ii) binds to albumin in a dose-dependent manner, (iii) is taken up by cells in a time-dependent way, (iv) has a higher capacity to induce cell death compared to cisplatin (IC50 = 6 μM vs. 10 μM), by altering the oxidative and mitochondrial status in HepG2 cells. Unlike cisplatin, which blocks the cell cycle in the S-phase, the new vanadium-based compound arrests it in S and G2/M-phase, whereas no differences in the induction of DNA fragmentation and reduction of β-Tubulin synthesis between the two were determined. Thus, the [(VVO)(L)(CH3O)]4 antitumor mechanism involved corroboration between the generation of oxidative species, mitochondrial dysfunction, degradation of DNA, cell cycle arrest in the S and G2/M-phase, and β-Tubulin synthesis reduction. Our studies demonstrate the potent antitumor activity of [(VVO)(L)(CH3O)]4 and propose it as an attractive candidate for anticancer therapy.

7 January 2024 in Crystals
Verified
Journal Article
Open access
PDF file
MCMihaela Cristea
Mihaela Cristea
MRMihai Raduca
Mihai Raduca
SSSergiu Shova
Sergiu Shova
CDConstantin Draghici
Constantin Draghici
Vlad Andrei NeacsuVlad Andrei Neacsu
Vlad Andrei Neacsu
FDFlorea Dumitrascu
Florea Dumitrascu
Novel 9-cyano-pyrrolo[1,2-a][1,10]phenanthrolines 6a–d were obtained by an efficient one-pot regioselective reaction between 1,10-phenanthrolinium bromides 2a–d and acrylonitrile as a dipolarophile, in the presence of triethylamine and tetrakis-pyridino-cobalt(II) dichromate (TPCD) as oxidizing agents. The optical properties of the compounds were investigated through UV–Vis spectrophotometry and steady-state photoluminescence measurements, while their structures were elucidated by single-crystal X-ray diffraction. The structural characterization revealed that the molecular structures of the four compounds were stabilized by hydrogen bonds and π–π interactions.

15 January 2025 in Crystals
Verified
Journal Article
Open access
PDF file
MPMarcel Mirel Popa
Marcel Mirel Popa
MRMihai Raduca
Mihai Raduca
IMIsabela Costinela Man
Isabela Costinela Man
FDFlorea Dumitrascu
Florea Dumitrascu
New secondary alcohols of type Ar-CHOH-hetaryl and MeCHOH-hetaryl, the radical hetaryl being a pyrroloazine, were investigated in solid state by X-ray single-crystal diffraction analysis, Hirshfeld analysis and DFT methods to assess their crystallographic features. One of the most important features is the presence of the hydroxyl group bonded to an asymmetric carbon atom which was involved in strong hydrogen bonds. The driving force of crystal packing is H-bond with the O-H···O=C/N≡C bonds being considered as strong comparative to carboxylic acids. These structural properties and binding affinity might lead to enhanced bioavailability of these particular pyrrolo-azines

9 October 2021 in Crystals
Verified
Journal Article
Open access
PDF file
MRMihai Raduca
Mihai Raduca
Augustin M. MadalanAugustin M. Madalan
Augustin M. Madalan
A series of nitrogen-containing organic molecules (4,4’-bipyridyl; trans-1,2-bis(4-pyridyl)ethylene; 1,2-bis(4-pyridyl)ethane; 4-aminopyridine and trans-1,4-diaminocyclohexane) was envisaged for cocrystallization experiments together with fluorescein. These compounds, containing pyridyl or/and amino nitrogen atoms, can act either as hydrogen bond acceptors for the phenol groups of fluorescein-generating cocrystals or as proton acceptors forming organic salts. Five cocrystals were obtained with the partners containing only pyridyl groups: {(H2Fl)2(bipy)} (1); {(H2Fl)2(bipy)(MeOH)2} (2); {(H2Fl)2(bpete)(EtOH)2} (3); {(H2Fl)(bpete)} (4); {(H2Fl)(bpeta)} (5). The compounds bearing amino groups deprotonate fluorescein producing salts: [(HFl)(Hampy)]∙2H2O (6); [(HFl)(Hampy)] (7); [(Fl)(H2diach)]∙3H2O (8); [(HFl)2(H2diach)]∙2H2O∙EtOH (9); and [(HFl)2(Fl)2(H2diach)3]∙4H2O (10). Optical properties of the cocrystals and salts were investigated.

13 December 2022 in Crystals
Verified
Journal Article
Open access
PDF file
MRMihai Raduca
Mihai Raduca
SISorana Ionescu
Sorana Ionescu
Augustin M. MadalanAugustin M. Madalan
Augustin M. Madalan
A heteroleptic homotrinuclear complex, [Zn3(valhydr)2(RhB)2(EtOH)2](ClO4)2 (H2valhydr = 1,2-bis(2-hydroxy-3-methoxybenzylidene)hydrazine, RhB = rhodamine B), was synthesized and structurally characterized by X-ray diffraction on single crystal. In the centrosymmetric complex, the zinc ions are positioned in a linear manner. The external zinc ions are pentacoordinated with a distorted square pyramidal stereochemistry, while the central zinc ion presents an elongated octahedral geometry. Luminescent properties of the complex were investigated in solid state and solution.